cckurugamestation.ru


ACAD STOCK FORECAST

The average stock forecast for ACADIA Pharmaceuticals Inc (ACAD) in the next 12 months is USD. This price target corresponds to an upside of %. The. The 19 analysts with month price forecasts for ACAD stock have an average target of , with a low estimate of 19 and a high estimate of The average. ACAD's current price target is $ Learn why top analysts are making this stock forecast for ACADIA Pharmaceuticals at MarketBeat. Get ACADIA Pharmaceuticals Inc (ACAD:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. ACADIA Pharmaceuticals' stock was trading at $ at the start of the year. Since then, ACAD stock has decreased by % and is now trading at $ View.

ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock, Analyst Ratings, Price Targets, Forecasts. ACADIA Pharmaceuticals Inc has a consensus price target of $ Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Bid Price and Ask Price. The bid & ask refers to the price that an. What was ACADIA Pharmaceuticals's price range in the past 12 months? ACADIA Pharmaceuticals lowest stock price was $ and its highest was $ in the past. ACAD - ACADIA Pharmaceuticals - Stock Forecast ACAD is currently covered by 25 analysts with an average price target of $ This is a potential upside of. The Acadia Pharmaceuticals stock price is USD today. Will ACAD stock price drop / fall? Yes. The Acadia Pharmaceuticals stock price may drop from The current price of ACAD is USD — it has increased by % in the past 24 hours. Watch ACADIA Pharmaceuticals Inc. stock price performance more closely. ACADIA Pharmaceuticals is forecast to grow earnings and revenue by % and % per annum respectively. EPS is expected to grow by % per annum. Return on. About the Acadia Pharmaceuticals Inc stock forecast As of August 25, Sunday current price of stock is $ and our data indicates that the asset. ACAD Comments Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your. Acadia Pharmaceuticals stock price target cut to $19 from $27 at Mizuho. Aug. 10, at a.m. ET by Tomi Kilgore. Acadia Pharmaceuticals stock price. The average one-year price target for ACADIA Pharmaceuticals Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price.

ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock, Analyst Ratings, Price Targets, Forecasts. ACADIA Pharmaceuticals Inc has a consensus price target of $ ACAD. %. S&P %. Compare To: ACAD. Compare. Select to analyze similar companies using key performance metrics; select up to 4 stocks. ACAD. ACADIA. The ACADIA Pharmaceuticals stock forecast for tomorrow is $ , which would represent a % gain compared to the current price. In the next week, the price. ACAD's current price target is $ Learn why top analysts are making this stock forecast for ACADIA Pharmaceuticals at MarketBeat. Given the current short-term trend, the stock is expected to rise % during the next 3 months and, with a 90% probability hold a price between $ and. Acadia Pharmaceuticals Inc (ACAD) Q3 Earnings Call Transcript. ACAD earnings call for the period ending November 8, Motley Fool Transcribers |. The forecasts range from a low of $ to a high of $ The average price target represents an increase of % from the last closing price of $ View ACADIA Pharmaceuticals Inc. ACAD stock quote prices, financial information, real-time forecasts, and company news from CNN. According to 18 analysts, the average rating for ACAD stock is "Buy." The month stock price forecast is $, which is an increase of % from the.

Over the last 12 months, its price fell by percent. Looking ahead, we forecast Acadia Pharmaceuticals to be priced at by the end of this quarter and. Earnings and Valuation · Earnings Growth. Earnings for ACADIA Pharmaceuticals are expected to grow by % in the coming year, from $ to $ per share. Research ACADIA Pharmaceuticals' (Nasdaq:ACAD) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock's expected. Stock Activity ; Open: ; Day Low: ; Day High: ; 52 Wk Low: ; 52 Wk High:

ACAD Stock, USD %. Given the investment horizon of 90 days and Unsystematic risk is the risk that events specific to ACADIA Pharmaceuticals or. Acadia Pharmaceuticals ACAD share price forecast & targets for Intra Day are , , on the downside, and , , on the upside. Acadia. These share price targets are working as support & resistance levels as well. Acadia Pharmaceuticals ACAD share price forecast & targets for mid-term is a. As per the chart shown above, analysts believe that the Acadia Pharmaceuticals Inc. (ACAD) share price will touch around $ in next months. The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction. ACAD EPS for the last quarter is USD despite the estimation of USD. In the next quarter EPS is expected to reach USD. Track more of ACADIA. Based on the Rule 16, the options market is currently suggesting that ACADIA Pharmaceuticals will have an average daily up or down price movement of about %.

Senior Singles Dating | Hut 8


Copyright 2014-2024 Privice Policy Contacts SiteMap RSS